About 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine)
3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine) (PubChem CID 159269751) has the molecular formula C55H45F9N24Pt3
and a molecular weight of 1798.35 g/mol. Its IUPAC name is 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine).
Molecular Properties
| Compound Name | 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine) |
| PubChem CID | 159269751 |
| Molecular Formula | C55H45F9N24Pt3 |
| Molecular Weight | 1798.35 g/mol |
| Exact Mass | 1797.31 |
| IUPAC Name | 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine) |
| SMILES | Cc1cc(-c2nccn2-c2ccccc2)[n-]n1.Cc1cc(-c2nccn2C(C)C)[n-]n1.Cc1cc(-c2nccn2C)[n-]n1.FC(F)(F)c1cc(-c2ccncn2)[n-]n1.FC(F)(F)c1cc(-c2ccncn2)[n-]n1.FC(F)(F)c1cc(-c2ccncn2)[n-]n1.[Pt+2].[Pt+2].[Pt+2] |
| InChI | InChI=1S/C13H11N4.C10H13N4.3C8H4F3N4.C8H9N4.3Pt/c1-10-9-12(16-15-10)13-14-7-8-17(13)11-5-3-2-4-6-11;1-7(2)14-5-4-11-10(14)9-6-8(3)12-13-9;3*9-8(10,11)7-3-6(14-15-7)5-1-2-12-4-13-5;1-6-5-7(11-10-6)8-9-3-4-12(8)2;;;/h2-9H,1H3;4-7H,1-3H3;3*1-4H;3-5H,1-2H3;;;/q6*-1;3*+2 |
| InChIKey | KXOABRIHONGYIC-UHFFFAOYSA-N |
| XLogP | 9.28 |
| TPSA | 292.74 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 91 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
| MW ≤ 500 | 1798.35 |
| LogP ≤ 5 | 9.28 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 18 |
Analyze 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine) with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine)?
The IUPAC name of 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine) (CID 159269751) is 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine).
What is the SMILES notation for 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine)?
The canonical SMILES for 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine) is Cc1cc(-c2nccn2-c2ccccc2)[n-]n1.Cc1cc(-c2nccn2C(C)C)[n-]n1.Cc1cc(-c2nccn2C)[n-]n1.FC(F)(F)c1cc(-c2ccncn2)[n-]n1.FC(F)(F)c1cc(-c2ccncn2)[n-]n1.FC(F)(F)c1cc(-c2ccncn2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine)?
The InChIKey is KXOABRIHONGYIC-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H11N4.C10H13N4.3C8H4F3N4.C8H9N4.3Pt/c1-10-9-12(16-15-10)13-14-7-8-17(13)11-5-3-2-4-6-11;1-7(2)14-5-4-11-10(14)9-6-8(3)12-13-9;3*9-8(10,11)7-3-6(14-15-7)5-1-2-12-4-13-5;1-6-5-7(11-10-6)8-9-3-4-12(8)2;;;/h2-9H,1H3;4-7H,1-3H3;3*1-4H;3-5H,1-2H3;;;/q6*-1;3*+2.
What are the key properties of 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine)?
3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine) has a molecular weight of 1798.35 g/mol, XLogP of 9.28, 8 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 3-methyl-5-(1-methylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-phenylimidazol-2-yl)pyrazol-1-ide;3-methyl-5-(1-propan-2-ylimidazol-2-yl)pyrazol-1-ide;tris(platinum(2+));tris(4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine) is sourced from PubChem (CID 159269751), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).